What is it about?
This is a post-hoc analysis of the long-term effects of safinamide 50 and 100 mg/day on dyskinesia using the DRS scale in fluctuating PD patients
Featured Image
Why is it important?
The findings of this post-hoc analysis suggest that safinamide could reduce the risk to develop troublesome dyskinesia through the inhibition of abnormal glutamate release mediated by the sodium channels blockade
Read the Original
This page is a summary of: Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis, Journal of Parkinson s Disease, September 2015, IOS Press,
DOI: 10.3233/jpd-150569.
You can read the full text:
Contributors
The following have contributed to this page